Concentration of total mycophenolic acid (MPA), mycophenolic acid glucuronide (MPAG) and unbound MPA in diabetic kidney transplant recipients.

被引:0
|
作者
Akhlaghi, F
Patel, CG
Zuinga, P
Lin, S
Yango, A
Gohh, R
机构
[1] Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA
[2] Rhode Isl Hosp, Brown Med Sch, Providence, RI USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
268
引用
收藏
页码:232 / 232
页数:1
相关论文
共 50 条
  • [41] Long-term (3 years) pharmacokinetics (PK) of mycophenolic acid (MPA) in pediatric renal transplant recipients
    Weber, L.
    Hoecker, B.
    Armstrong, V.
    Oellerich, M.
    Toenshoff, B.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1446 - 1446
  • [42] Marked Alterations in Gene Expression in Peripheral Blood Leukocytes of Kidney Transplant (tx) Recipients Following Mycophenolic Acid (MPA) Treatment.
    Sanghavi, K.
    Wu, B.
    Dorr, C.
    Muthuswamy, A.
    Guan, W.
    Schladt, D.
    Remmel, R.
    Ilke, D.
    Matas, A.
    Israni, A.
    Oetting, W.
    Jacobson, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 783 - 783
  • [43] Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients
    Sheng, Changcheng
    Zhao, Qun
    Niu, Wanjie
    Qiu, Xiaoyan
    Zhang, Ming
    Jiao, Zheng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [44] Population pharmacokinetic (PK) model of mycophenolic acid (MPA) and its metabolite - Mycophenolic acid glucoronide (MPAG) in long term transplant renal patients using Montecarlo parametric expectation maximization (MC-PEM).
    Okusanya, O. O.
    Dole, K.
    Zack, J.
    Forrest, A.
    Gundroo, A.
    Leca, N.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S72 - S72
  • [45] Optimisation of Mycophenolic Acid (MPA) Exposure for Early Steroid Withdrawal in Kidney Graft Recipients: The OPERA Trial.
    Le Meur, Y.
    Touchard, G.
    Glowacki, F.
    Rerolle, J. P.
    Garrigue, V.
    Ouali, N.
    Heng, A. E.
    Delahousse, M.
    Albano, L.
    Couzi, L.
    Lang, P.
    Westeel, P. F.
    Allano, F.
    Tagieva, N.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 341 - 341
  • [46] Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry
    Patel, CG
    Mendonza, AE
    Akhlaghi, F
    Majid, O
    Trull, AK
    Lee, T
    Holt, DW
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 813 (1-2): : 287 - 294
  • [47] Glucuronidation of mycophenolic acid (MPA) in vitro by human liver microsomes
    Desroches, M. C.
    Potin, S.
    Furlan, V.
    Taburet, A. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 64 - 64
  • [48] Establishing a limited sampling strategy for mycophenolic acid monitoring in lung transplant recipients.
    Partovi, N
    Ting, LSL
    Ensom, MHH
    Riggs, W
    Levy, RD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 346 - 346
  • [49] Pharmacokinetics of mycophenolic acid after the conversion from mycophenolate sodium to the mofetil formulation in kidney transplant recipients.
    Merlini, Simona
    Baldelli, Sara
    Nicastri, Annalisa
    Bartolini, Barbara
    Perico, Norberto
    Gotti, Eliana
    Remuzzi, Giuseppe
    Cattaneo, Dario
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 347 - 348
  • [50] Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients
    Jung, Hee-Yeon
    Lee, Sukyung
    Jeon, Yena
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Hyung-Kee
    Huh, Seung
    Won, Dong Il
    Kim, Chan-Duck
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (24)